top of page

The Way Forward Is Clearer, Together.
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.


Women's Cancer Research Foundation
Apr 19, 20221 min read
Lighting the Way for Improved Detection of Ovarian Cancer
Pafolacianine, an imaging drug that can help surgeons identify ovarian cancer lesions, has recently been accorded FDA approval.
0 comments


Women's Cancer Research Foundation
Apr 11, 20221 min read
Breast Cancer and Community-Based Oncology Depression Screening Program
Researchers sought to examine if a greater proportion of breast cancer referrals to behavioral health could be achieved for patients in...
0 comments


Women's Cancer Research Foundation
Apr 7, 20221 min read
Cancer Risks Associated with BRCA1 and BRCA2 Pathogenic Variants
In a recent study, age-specific risk estimates of cancers, excluding breast and ovarian cancer, associated with pathogenic variants in...
0 comments


Women's Cancer Research Foundation
Apr 5, 20221 min read
Human Papillomavirus Infection Determines Prognosis in Cervical Cancer
Clinical research has identified a strong association between the detection of human papillomavirus (HPV) and invasive cervical cancer...
0 comments

Women's Cancer Research Foundation
Mar 31, 20222 min read
Breast Cancer 2021
Breast cancer incidence has recently increased by 0.5% per year in the US and remains the 2nd leading cause of cancer death in women.
0 comments


Women's Cancer Research Foundation
Mar 28, 20221 min read
Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers
Women with a BRCA 1 or 2 mutation carriers have an increased risk of developing breast cancer and ovarian cancer. However....
0 comments


Women's Cancer Research Foundation
Mar 25, 20221 min read
Use of Beta‐Blockers and Risk of Contralateral Breast Cancer
There has been some speculation that beta-blockers possess anti-cancer properties. Hence, researchers endeavored to retrieve...
0 comments


Women's Cancer Research Foundation
Mar 22, 20221 min read
A Novel Treatment For Platinum-Resistant Ovarian Cancer
Every year in the U.S., 22,000 to 24,000 women are diagnosed with ovarian cancer. Patient survival depends upon the responses to...
0 comments


Women's Cancer Research Foundation
Mar 16, 20221 min read
Racial Disparities in Non-Recommendation of Adjuvant Chemotherapy in Ovarian Cancer
In a recent study from Gynecologic Oncology, the authors identified ovarian cancer patients who underwent primary surgery from 2004 to 2015.
0 comments


Women's Cancer Research Foundation
Mar 10, 20221 min read
Overall Survival and Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer
In a recent JAMA study, researchers endeavored to determine if there were differences in overall survival among ovarian cancer patients...
0 comments


Women's Cancer Research Foundation
Mar 8, 20222 min read
Why Black Women with Ovarian Cancer Require Greater Focus
While mortality due to ovarian cancer is decreasing overall, Black women continue to have lower survival rates and higher rates of disease..
0 comments


Women's Cancer Research Foundation
Mar 2, 20221 min read
Ovarian Cancer Update
Last year, an estimated 314,000 people worldwide developed ovarian cancer, a condition associated with a 50% mortality rate.
0 comments


Women's Cancer Research Foundation
Feb 25, 20222 min read
4 in 10 Fractures in Breast Cancer Patients Are Pathologic
Breast cancer is associated with an increased fracture risk, attributed in part to estrogen deficiency, aromatase inhibitors frailty, and..
0 comments


Women's Cancer Research Foundation
Feb 11, 20222 min read
Certain Cancers Increase Stroke Risk, New Analysis Confirms
A 2021 systematic review from Journal of Cancer Survivorship revealed that people living with select cancers have a significantly higher...
0 comments


Women's Cancer Research Foundation
Feb 9, 20221 min read
Sugary Food and Beverage Consumption and the Risk of Developing Ovarian Cancer
Select researchers have inquired if refined sugars contribute to the manifestation of Ovarian Cancer.
0 comments


Women's Cancer Research Foundation
Jan 27, 20221 min read
Body Mass Index and Risk of Second Cancer Among Women with Breast Cancer
Recent Study: significantly increased risk of second cancers observed with breast cancer survivors who exhibited an increase in BMI.
0 comments


Women's Cancer Research Foundation
Jan 26, 20222 min read
Women's Cancer Research Foundation Welcomes New Board Member
Women's Cancer Research Foundation (WCRF) is pleased to announce our new Board Member, Jerry Burton.
0 comments


Women's Cancer Research Foundation
Jan 21, 20222 min read
Obesity and Cancer Death Among White and Black Adults
Recent study will inform us about interventions and policies that can reduce disparities in cancer death amongst White and Black Adults.
0 comments


Women's Cancer Research Foundation
Jan 6, 20222 min read
The Importance of Observation
The importance of individual observation though are key to discovery, analysis and development of new treatments and technologies.
0 comments


Women's Cancer Research Foundation
Dec 23, 20212 min read
Chemo Brain Is Real
“Chemo brain” refers to thinking that is sluggish or fuzzy. Essentially, this condition can interfere with executive functioning...
0 comments
bottom of page